Literature DB >> 29742915

Redox Regulation of Hexokinases.

Petr Heneberg1.   

Abstract

SIGNIFICANCE: Hexokinases are key enzymes that are responsible for the first reaction of glycolysis, but they also moonlight other cellular processes, including mitochondrial redox signaling regulation. Modulation of hexokinase activity and spatiotemporal location by reactive oxygen and nitrogen species as well as other gasotransmitters serves as the basis for a unique, underexplored method of tight and flexible regulation of these fundamental enzymes. Recent Advances: Redox modifications of thiols serve as a molecular code that enables the precise and complex regulation of hexokinases. Redox regulation of hexokinases is also used by multiple parasites to cause widespread and severe diseases, including malaria, Chagas disease, and sleeping sickness. Redox-active molecules affect each other, and the moonlighting activity of hexokinases provides another feedback loop that affects the cellular redox status and is hijacked in malignantly transformed cells. CRITICAL ISSUES: Several compounds affect the redox status of hexokinases in vivo. These include the dehydroascorbic acid (oxidized form of vitamin C), pyrrolidinium porrolidine-1-carbodithioate (contraceptive), peroxynitrite (product of ethanol metabolism), alloxan (a glucose analog), and isobenzothiazolinone ebselen. However, very limited information is available regarding which amino acid residues in hexokinases are affected by redox signaling. Except in cases of monogenic diabetes, direct evidence is absent for disease phenotypes that are associated with variations within motifs that are susceptible to redox signaling. FUTURE DIRECTIONS: Further studies should address the propensity of hexokinases and their disease-associated variants to participate in redox regulation. Robust and straightforward proteomic methods are needed to understand the context and consequences of hexokinase-mediated redox regulation in health and disease.

Entities:  

Keywords:  Chagas disease; alloxan diabetes; cancer; malaria; maturity-onset diabetes of the young; sleeping sickness

Mesh:

Substances:

Year:  2018        PMID: 29742915     DOI: 10.1089/ars.2017.7255

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  Cellular Compartmentation and the Redox/Nonredox Functions of NAD.

Authors:  Chaitanya A Kulkarni; Paul S Brookes
Journal:  Antioxid Redox Signal       Date:  2019-03-26       Impact factor: 8.401

Review 2.  Insulin, Muscle Glucose Uptake, and Hexokinase: Revisiting the Road Not Taken.

Authors:  David H Wasserman
Journal:  Physiology (Bethesda)       Date:  2021-11-15

Review 3.  Targeting mitochondrial metabolism for metastatic cancer therapy.

Authors:  Antonino Passaniti; Myoung Sook Kim; Brian M Polster; Paul Shapiro
Journal:  Mol Carcinog       Date:  2022-06-20       Impact factor: 5.139

4.  Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Authors:  Cristina Banella; Gianfranco Catalano; Serena Travaglini; Elvira Pelosi; Tiziana Ottone; Alessandra Zaza; Gisella Guerrera; Daniela Francesca Angelini; Pasquale Niscola; Mariadomenica Divona; Luca Battistini; Maria Screnci; Emanuele Ammatuna; Ugo Testa; Clara Nervi; Maria Teresa Voso; Nelida Ines Noguera
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

5.  Quantitative Estimation of Oxidative Stress in Cancer Tissue Cells Through Gene Expression Data Analyses.

Authors:  Liyang Liu; Haining Cui; Ying Xu
Journal:  Front Genet       Date:  2020-05-19       Impact factor: 4.599

6.  Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin.

Authors:  Daniela Šimčíková; Dominik Gardáš; Kateřina Hložková; Martin Hruda; Petr Žáček; Lukáš Rob; Petr Heneberg
Journal:  Cancer Metab       Date:  2021-12-11

7.  Cyclooxygenase-2 Glycosylation Is Affected by Peroxynitrite in Endothelial Cells: Impact on Enzyme Activity and Degradation.

Authors:  Sonia Eligini; Susanna Colli; Aida Habib; Giancarlo Aldini; Alessandra Altomare; Cristina Banfi
Journal:  Antioxidants (Basel)       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.